Sofosbuvir, GS-9857 and velpatasvir triple therapy for chronic hepatitis C

NIHR HSRIC
Record ID 32016000751
English
Authors' recommendations: Hepatitis C is a virus that causes inflammation of the liver. The virus is present in the blood of people with the infection, and this can infect others that come into contact with it. The virus is most commonly passed on by needles contaminated with infected blood, but it is also spread occasionally through unprotected sex. Most people with hepatitis C will have it for many years and they may or may not have symptoms. If the virus is untreated, it can lead to serious liver disease, such as liver cirrhosis and cancer. Sofosbuvir, GS-9857 and velpatasvir is a new combination of drugs that is taken by mouth as a single tablet to treat hepatitis C infection. Some studies have suggested that this combination drug can clear the body of the virus at least as well as treatment already available and in a shorter time. It may also be helpful for people whose infection has not been cured by current treatments. More studies are trying to show that the drug is safe to use. If sofosbuvir, GS-9857 and velpatasvir fixed dose combination is licensed for use in the UK, it could be a new treatment option for people with hepatitis C virus, regardless of whether they have already received treatment.
Details
Project Status: Completed
Year Published: 2016
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: England, United Kingdom
MeSH Terms
  • Drug Therapy, Combination
  • Antiviral Agents
  • Hepatitis C, Chronic
  • Sofosbuvir
  • Uridine Monophosphate
Contact
Organisation Name: NIHR Horizon Scanning Centre
Contact Address: The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health and Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269
Contact Name: c.packer@bham.ac.uk
Contact Email: c.packer@bham.ac.uk
Copyright: NIHR Horizon Scanning Research&Intelligence Centre (NIHR HSRIC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.